Focal and diffuse cervical spinal cord damage in patients with early relapsing-remitting MS: A multicentre magnetisation transfer ratio study.


Journal

Multiple sclerosis (Houndmills, Basingstoke, England)
ISSN: 1477-0970
Titre abrégé: Mult Scler
Pays: England
ID NLM: 9509185

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 19 6 2018
medline: 20 3 2020
entrez: 19 6 2018
Statut: ppublish

Résumé

Studies including patients with well-established multiple sclerosis (MS) have shown a significant and disability-related reduction in the cervical spinal cord (SC) magnetisation transfer ratio (MTR). The objectives are to (1) assess whether MTR reduction is already measurable in the SC of patients with early relapsing-remitting multiple sclerosis (RRMS) and (2) describe its spatial distribution. We included 60 patients with RRMS <12  months and 34 age-matched controls at five centres. Axial T2*w, sagittal T2w, sagittal phase-sensitive inversion recovery (PSIR), 3DT1w, and axial magnetisation transfer (MT) images were acquired from C1 to C7. Lesions were manually labelled and mean MTR values computed both for the whole SC and for normal-appearing SC in different regions of interest. Mean whole SC MTR was significantly lower in patients than controls (33.7 vs 34.9  pu, Cervical SC tissue damage measured using MTR is not restricted to macroscopic lesions in patients with early RRMS and is not homogeneously distributed.

Sections du résumé

BACKGROUND
Studies including patients with well-established multiple sclerosis (MS) have shown a significant and disability-related reduction in the cervical spinal cord (SC) magnetisation transfer ratio (MTR).
OBJECTIVES
The objectives are to (1) assess whether MTR reduction is already measurable in the SC of patients with early relapsing-remitting multiple sclerosis (RRMS) and (2) describe its spatial distribution.
METHODS
We included 60 patients with RRMS <12  months and 34 age-matched controls at five centres. Axial T2*w, sagittal T2w, sagittal phase-sensitive inversion recovery (PSIR), 3DT1w, and axial magnetisation transfer (MT) images were acquired from C1 to C7. Lesions were manually labelled and mean MTR values computed both for the whole SC and for normal-appearing SC in different regions of interest.
RESULTS
Mean whole SC MTR was significantly lower in patients than controls (33.7 vs 34.9  pu,
CONCLUSION
Cervical SC tissue damage measured using MTR is not restricted to macroscopic lesions in patients with early RRMS and is not homogeneously distributed.

Identifiants

pubmed: 29909771
doi: 10.1177/1352458518781999
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1113-1123

Auteurs

Benoît Combès (B)

IRISA, UMR CNRS 6074, VisAGeS U1228, INSERM, INRIA, Université Rennes I, Rennes, France.

Anne Kerbrat (A)

IRISA, UMR CNRS 6074, VisAGeS U1228, INSERM, INRIA, Université Rennes I, Rennes, France.
Neurology Department, Rennes University Hospital, Rennes, France.

Jean Christophe Ferré (JC)

IRISA, UMR CNRS 6074, VisAGeS U1228, INSERM, INRIA, Université Rennes I, Rennes, France.
Radiology Department, CHU Rennes, Rennes, France.

Virginie Callot (V)

AP-HM, Pôle d'Imagerie Médicale, Hôpital de La Timone, CEMEREM, Marseille, France.
Aix-Marseille Université, CNRS, UMR 7339, CRMBM, Marseille, France.

Josefina Maranzano (J)

MNI, Montreal, QC, Canada.

Atef Badji (A)

Institute of Biomedical Engineering, Polytechnique Montreal, Montreal, QC, Canada; Functional Neuroimaging Unit, CRIUGM, Université de Montreal, Montreal, QC, Canada.

Emmanuelle Le Page (E)

Neurology Department, Rennes University Hospital, Rennes, France.

Pierre Labauge (P)

Montpellier University Hospital, Montpellier, France.

Xavier Ayrignac (X)

Montpellier University Hospital, Montpellier, France.

Clarisse Carra Dallière (C)

Montpellier University Hospital, Montpellier, France.

Nicolas Menjot de Champfleur (NM)

Montpellier University Hospital, Montpellier, France.

Jean Pelletier (J)

AP-HM, Pôle d'Imagerie Médicale, Hôpital de La Timone, CEMEREM, Marseille, France.
AP-HM, CHU Timone, Pole de Neurosciences Cliniques, Department of Neurology, Marseille, France.

Adil Maarouf (A)

AP-HM, Pôle d'Imagerie Médicale, Hôpital de La Timone, CEMEREM, Marseille, France.
AP-HM, CHU Timone, Pole de Neurosciences Cliniques, Department of Neurology, Marseille, France.

Jérôme de Seze (J)

CIC, INSERM 1434, University Hospital of Strasbourg, Strasbourg, France.

Nicolas Collongues (N)

CIC, INSERM 1434, University Hospital of Strasbourg, Strasbourg, France.

David Brassat (D)

Université de Toulouse, Toulouse, France.

Françoise Durand-Dubief (F)

Lyon University Hospital, Lyon, France.

Christian Barillot (C)

IRISA, UMR CNRS 6074, VisAGeS U1228, INSERM, INRIA, Université Rennes I, Rennes, France.

Elise Bannier (E)

IRISA, UMR CNRS 6074, VisAGeS U1228, INSERM, INRIA, Université Rennes I, Rennes, France.
Radiology Department, CHU Rennes, Rennes, France.

Gilles Edan (G)

IRISA, UMR CNRS 6074, VisAGeS U1228, INSERM, INRIA, Université Rennes I, Rennes, France.
Neurology Department, Rennes University Hospital, Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH